LET0010W - Letrozole, 2.5mg, 1 x 28 (Expiry 28.02.2025)

Letrozole 2.5mg Tablets 28 Pack

Adjuvant treatment of postmenopausal women with hormone receptor positive invasive early breast cancer.

Extended adjuvant treatment of hormone-dependent early invasive breast cancer in postmenopausal women who have received prior standard adjuvant tamoxifen therapy for 5 years.


First-line treatment in postmenopausal women with hormone-dependent advanced breast cancer.


Advanced breast cancer after relapse or disease progression, in women with natural or artificially induced postmenopausal endocrine status, who have previously been treated with antioestrogens.


Neoadjuvant treatment of postmenopausal women with hormone receptor positive, HER-2 negative breast cancer where chemotherapy is not suitable and immediate surgery not indicated.